RBC Capital Markets adjusted its outlook on Meta Platforms Inc. (NASDAQ: NASDAQ:META), increasing the price target to $800 from the previous $700 while maintaining an Outperform rating on the stock. The new target reflects growing confidence in the company,

Travelers Companies Inc. (NYSE:TRV), a $54.7 billion insurance giant trading at 11.5x earnings, received an upgrade in its stock rating from Piper Sandler analysts, shifting from Neutral to Overweight.

In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on The Estée Lauder Companies (EL – Research Report),

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of

In addition to Piper Sandler, Valley National Bancorp also received a Hold from Citi’s Ben Gerlinger in a report issued today. However, on January 23, RBC Capital assigned a Buy rating to Valley ...

Canaccord Genuity analysts downgraded Intra-Cellular Therapies (NASDAQ:ITCI) stock from Buy to Hold, adjusting the price target to $132 from the previous $119. The revision follows the recent announcement that Johnson & Johnson (JNJ) is set to acquire Intra-Cellular Therapies for a total equity value of $14.

Piper Sandler raised the firm’s price target on UMB Financial (UMBF) to $143 from $142 and keeps an Overweight rating on the shares. The firm

In a report released today, John Barnidge from Piper Sandler maintained a Sell rating on Ameriprise Financial (AMP – Research Report), with a

Jefferies analyst Brent Thill increased the price target on Meta Platforms Inc. (NASDAQ: NASDAQ:META) shares, moving it up to $810 from the previous $715, while reiterating a Buy rating on the stock.

MINNEAPOLIS, January 23, 2025--Piper Sandler ... to best access the debt capital markets with customized structures and NEW YORK, October 28, 2024--Piper Sandler Companies (NYSE: PIPR), a leading ...

StockNews.com lowered shares of Travelers Companies (NYSE:TRV – Free Report) from a buy rating to a hold rating in a research note released on Thursday morning. A number of other brokerages have also issued reports on TRV.

That's changed: Lyons is acknowledged heir apparent at a giant fintech where he'll become CEO by July at the latest.